Net profit falls at two Turkish companies in third quarter
Third-quarter results show lower net profit in lira at GEN İlaç and TAB Gıda compared with a year earlier, according to Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Turkish pharmaceutical company GEN İlaç ve Sağlık Ürünleri reported on Monday that its third-quarter net profit came to 120.7 million lira, down from 279.9 million lira a year earlier. Revenue also declined, to 5.7 billion lira from 6.9 billion lira.
Food producer TAB Gıda Sanayi ve Ticaret posted third-quarter net profit of 628.7 million lira, versus 1.2 billion lira a year earlier. Its revenue rose to 16.7 billion lira from 16.0 billion lira. The figures were reported by Reuters.
why it matters
Both reports show profit falling faster than sales, which points to shrinking margins at the two companies. For investors in Turkish stocks, this is a sign of earnings pressure, though these two releases alone do not set the direction of the wider market.
tags
instruments
sources
- GEN Ilac Q3 Net Profit Shrinks To 120.7 Mln Lira YoY — Reuters, 27 October 2026 at 05:17 UTC
- TAB Gida Q3 Net Profit Shrinks To 628.7 Mln Lira YoY — Reuters, 27 October 2026 at 05:17 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗